Inactive Ingredient Search for Approved Drug Products
Search Names Beginning with N
| Inactive Ingredient | Route | Dosage Form | CAS Number | UNII | Maximum Potency per unit dose | Maximum Daily Exposure (MDE) | Record Updated |
|---|---|---|---|---|---|---|---|
| N,N-DIMETHYLACETAMIDE | INTRAVENOUS | INJECTION | 127195 | JCV5VDB3HY | 11539mg | ||
| N,N-DIMETHYLACETAMIDE | INTRAVENOUS | INJECTION, SOLUTION | 127195 | JCV5VDB3HY | 30.91%w/v | ||
| N,N-DIMETHYLACETAMIDE | NASAL | SPRAY | 127195 | JCV5VDB3HY | 0.01ml | ||
| N-ACETYL-D-ALANINE | INTRAVENOUS | INJECTION, SOLUTION | 19436523 | IIE41SBQ9L | 5430mg | ||
| NAPHTHOL BLUE BLACK | ORAL | TABLET | 1064488 | SZT789770M | 0.83mg | ||
| N-DODECYL .BETA.-D-MALTOSIDE | NASAL | SPRAY | 69227936 | DI107E57B4 | 1mg | ||
| NEOTAME | ORAL | POWDER, FOR SOLUTION | 165450179 | VJ597D52EX | 14mg | ||
| NEUTRAL OIL | ORAL | CAPSULE, EXTENDED RELEASE | NA | 240mg | |||
| NIACINAMIDE | INTRAMUSCULAR | INJECTION | 98920 | 25X51I8RD4 | 2.5%w/v | ||
| NIACINAMIDE | INTRAVENOUS | INJECTION | 98920 | 25X51I8RD4 | 2.5%w/v | ||
| NIACINAMIDE | TOPICAL | CREAM | 98920 | 25X51I8RD4 | NA | ||
| NIACINAMIDE | TOPICAL | GEL | 98920 | 25X51I8RD4 | 25mg | ||
| NITRIC ACID | INTRAVENOUS | INJECTION | 7697372 | 411VRN1TV4 | ADJ PH | ||
| NITRIC ACID | RESPIRATORY (INHALATION) | AEROSOL, METERED | 7697372 | 411VRN1TV4 | 0.86%w/w | ||
| NITRIC ACID | RESPIRATORY (INHALATION) | AEROSOL, SPRAY | 7697372 | 411VRN1TV4 | 0.8%w/w | ||
| NITRIC ACID | TOPICAL | CREAM | 7697372 | 411VRN1TV4 | ADJ PH | ||
| NITRIC ACID | TOPICAL | SOLUTION | 7697372 | 411VRN1TV4 | ADJ PH | ||
| NITRIC ACID | VAGINAL | CREAM | 7697372 | 411VRN1TV4 | ADJ PH | ||
| NONCRYSTALLIZING SORBITOL SOLUTION | ORAL | CAPSULE | 9E0S3UM200 | 144mg | |||
| NONCRYSTALLIZING SORBITOL SOLUTION | ORAL | SOLUTION | 9E0S3UM200 | 24000mg | |||
| NONCRYSTALLIZING SORBITOL SOLUTION | ORAL | SUSPENSION | 9E0S3UM200 | 45000mg | |||
| NONCRYSTALLIZING SORBITOL SOLUTION | ORAL | SYRUP | 9E0S3UM200 | 6200mg | |||
| NONOXYNOL-40 | TOPICAL | LIQUID | 26027383 | 4867M0AEJI | 3%w/w | ||
| NONOXYNOL-40 | VAGINAL | DOUCHE | 26027383 | 4867M0AEJI | 0.25%w/w | ||
| NONOXYNOL-9 | OPHTHALMIC | SOLUTION | 26027383 | 48Q180SH9T | 0.13%w/w | ||
| NONOXYNOL-9 | TOPICAL | CLOTH | 26027383 | 48Q180SH9T | NA | ||
| NORFLURANE | NASAL | AEROSOL | 811972 | DH9E53K1Y8 | 217mg | ||
| NORFLURANE | ORAL | AEROSOL, METERED | 811972 | DH9E53K1Y8 | 433mg | ||
| NORFLURANE | RESPIRATORY (INHALATION) | AEROSOL, METERED | 811972 | DH9E53K1Y8 | 685mg | ||
| N-PHENYL-1-NAPTHYLAMINE | RESPIRATORY (INHALATION) | LIQUID | 90302 | 5I112077IN | 0.01%w/w | ||
| NUTMEG OIL | ORAL | ELIXIR | 8008455 | Z1CLM48948 | 4.5mg/5ml | ||
| NUTMEG OIL | RESPIRATORY (INHALATION) | LIQUID | 8008455 | Z1CLM48948 | NA |
FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections: IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly
Data Through: January 5, 2024
Database Last Updated: January 26, 2024